- Home
- NTIP vs COCH Comparison
NTIP vs COCH Comparison
Compare NTIP & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTIP
- COCH
- Stock Information
- Founded
- NTIP 1990
- COCH 1995
- Country
- NTIP United States
- COCH United States
- Employees
- NTIP N/A
- COCH N/A
- Industry
- NTIP Multi-Sector Companies
- COCH Blank Checks
- Sector
- NTIP Miscellaneous
- COCH Finance
- Exchange
- NTIP Nasdaq
- COCH Nasdaq
- Market Cap
- NTIP 28.6M
- COCH 31.6M
- IPO Year
- NTIP 1998
- COCH N/A
- Fundamental
- Price
- NTIP $1.20
- COCH $1.46
- Analyst Decision
- NTIP
- COCH Strong Buy
- Analyst Count
- NTIP 0
- COCH 2
- Target Price
- NTIP N/A
- COCH $9.25
- AVG Volume (30 Days)
- NTIP 13.9K
- COCH 19.6K
- Earning Date
- NTIP 08-11-2025
- COCH 08-11-2025
- Dividend Yield
- NTIP 8.00%
- COCH N/A
- EPS Growth
- NTIP N/A
- COCH N/A
- EPS
- NTIP N/A
- COCH N/A
- Revenue
- NTIP $250,000.00
- COCH $212,000.00
- Revenue This Year
- NTIP N/A
- COCH $8.04
- Revenue Next Year
- NTIP N/A
- COCH $15.39
- P/E Ratio
- NTIP N/A
- COCH N/A
- Revenue Growth
- NTIP N/A
- COCH N/A
- 52 Week Low
- NTIP $1.16
- COCH $1.21
- 52 Week High
- NTIP $1.78
- COCH $3.99
- Technical
- Relative Strength Index (RSI)
- NTIP 44.51
- COCH 48.52
- Support Level
- NTIP $1.21
- COCH $1.40
- Resistance Level
- NTIP $1.30
- COCH $1.58
- Average True Range (ATR)
- NTIP 0.05
- COCH 0.09
- MACD
- NTIP -0.00
- COCH 0.01
- Stochastic Oscillator
- NTIP 28.57
- COCH 47.83
About NTIP Network-1 Technologies Inc.
Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property assets. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.